BIRC3 and B-cell chronic lymphocytic leukemia: Moreover, BIRC3 mutations have also been found to be enriched in fludarabine relapsed/refractory CLL cases in some cohorts [10, 18], although the mechanistic insights by which BIRC3 mutations could contribute to fludarabine resistance have not been elucidated.